Announcement on Convening Performance Briefing for 2025 and Q1 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening Performance Briefing for 2025 and Q1 2026
Filed with SSE · · 3 pages · Chinese
Release
China National Medicines Corporation Ltd. on 6ix
Earlier from China National Medicines
- Announcement on Renewing Engagement of Accounting Firm for 2026
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Amending Some Clauses of the Articles of Association
- Announcement on Return of Raised Funds Temporarily Used to Supplement Current Capital
- Announcement on Increasing Estimated Amount of Daily Related Party Transactions in 2025
Later from China National Medicines
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
- Notice on the 2nd Extraordinary General Meeting in 2026
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Announcement on Opening of a Special Account for Temporarily Supplementing Working Capital with Raised Funds and Signing of a Regulatory Agreement
Follow China National Medicines into a list and get an email when it puts out news.
Follow China National Medicines